[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100459654":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":78,"collaborators":10,"id":81,"slug":82,"hasResults":83,"nctId":84,"briefTitle":85,"officialTitle":85,"acronym":10,"eligibilityCriteria":86,"healthyVolunteers":83,"sex":87,"minAge":88,"maxAge":10,"enrollmentInfo":89,"targetDuration":10,"studyType":92,"phases":10,"briefSummary":93,"conditions":94,"keywords":98,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Data\u002FBiospecimen Collection",null,"Tumor and saliva specimens from participants with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) diagnosed at age 45 or younger",[13],"Genetic: Data and Specimen Collection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"GENETIC","Data and Specimen Collection","* Provide research team access to relevant medical records\n* Answer two (2) short questionnaires at time of consent\n* Provide up to 5 tubes (37 ml) of blood at or near the time of consent, and\u002For saliva sample\n* Consider consenting to other optional parts of the research such as:\n\n  * Providing additional blood or tissue samples in the future (optional)\n  * Providing permission for obtainment of stored tissue specimens from lung cancer surgeries or biopsies from the pathology departments where they have been stored (optional)",[9],[21],{"name":22,"affiliation":5,"role":23},"Pasi A Janne, MD, PhD","PRINCIPAL_INVESTIGATOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","617-632-6036","Pasi_Janne@dfci.harvard.edu",[30,51,63,71],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Massachusetts General Hospital","RECRUITING","Boston","Massachusetts","02114","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-71.05977,42.35843,{"lat":42,"lon":41},[45,49],{"name":46,"role":26,"phone":47,"phoneExt":10,"email":48},"Jessica Line, MD","617-724-1134","jjlin1@partners.org",{"name":50,"role":23,"phone":10,"phoneExt":10,"email":10},"Jessica Lin, MD",{"facility":52,"status":53,"city":33,"state":34,"zip":54,"country":36,"countryCode":37,"cosmosGeoPoint":55,"geoPoint":57,"contacts":58},"Beth Israel Deaconess Medical Center","NOT_YET_RECRUITING","02115",{"type":39,"coordinates":56},[41,42],{"lat":42,"lon":41},[59,62],{"name":60,"role":26,"phone":61,"phoneExt":10,"email":10},"Daniel Costa, MD PhD","617-667-9236",{"name":60,"role":23,"phone":10,"phoneExt":10,"email":10},{"facility":64,"status":53,"city":33,"state":34,"zip":54,"country":36,"countryCode":37,"cosmosGeoPoint":65,"geoPoint":67,"contacts":68},"Brigham and Women's Hospital",{"type":39,"coordinates":66},[41,42],{"lat":42,"lon":41},[69,70],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"facility":5,"status":32,"city":33,"state":34,"zip":54,"country":36,"countryCode":37,"cosmosGeoPoint":72,"geoPoint":74,"contacts":75},{"type":39,"coordinates":73},[41,42],{"lat":42,"lon":41},[76,77],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":23,"investigatorFullName":79,"investigatorTitle":80,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Pasi Janne, MD, PhD","Principal Investigator","100459654","biology-of-young-lung-cancer-study-the-young-lung-study-100459654",false,"NCT05265429","Biology of Young Lung Cancer Study: The YOUNG LUNG Study","Inclusion Criteria:\n\n* Age 45 and under at lung cancer diagnosis\n* Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point\n* Provision of written informed consent\n* Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks\n* Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent\n\nExclusion Criteria:\n\n* Individuals who decline to sign consent\n* Individuals who are unable to give consent or assent and are without a designated healthcare proxy\n* Compromise of patient diagnosis or staging if tissue is used for research","ALL","15 Years",{"count":90,"type":91},500,"ESTIMATED","OBSERVATIONAL","The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.",[95,96,97],"Non Small Cell Lung Cancer","Small Cell Lung Carcinoma","NUT Carcinoma",[95,96,99,100,101],"Genetics","Genomics","Young lung cancer","2025-10-28",{"date":104,"type":105},"2025-10-29","ACTUAL",{"date":107,"type":105},"2023-01-01",{"date":109,"type":91},"2027-08-01",{"name":5,"class":6},4]